T2 Biosystems Sponsored Session: Advancing Sepsis Detection in ICUs: Assessing the Benefits and Integration of T2Candida in Clinical Practice
Description:
Date/Time: September 26, 2024 | 1:25 - 1:40 pm ET
Candida infections in the ICU are particularly problematic due to their high mortality rates, the difficulty in rapid and accurate diagnosis, and the subsequent delays in initiating appropriate antifungal therapy. This session will discuss implementing the T2Candida Panel in ICU settings, where we will explore its impact on sepsis care. Topics include an introduction to the T2Candida diagnostic panel, identifying appropriate patient populations for testing, comparing T2Candida with Beta-D-Glucan, and best practices for integrating T2Candida into ICU workflows.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Cristian Merchan, Pharm.D., BCCCP
Assistant Director of Clinical Pharmacy Services - Critical Care, Emergency and Perioperative Services
NYU Langone Health
Cristian Merchan, Pharm.D., BCCCP, is a board-certified critical care pharmacist actively involved in rounds within the cardiothoracic unit, specializing in managing patients with advanced heart failure requiring acute mechanical circulatory support and those undergoing complex cardiac surgeries. He has an extensive publication history in critical care pharmacy, contributing over 30 publications. His research interests center around drug-induced diseases and interactions, optimizing drug dosage regimens for specialized ICU populations, and leveraging laboratory tests to inform medication management.
Summit 2024 Session: T2 Biosystems Sponsored Session: Advancing Sepsis Detection in ICUs: Assessing the Benefits and Integration of T2Candida in Clinical Practice
Session Day/Time: Thursday, September 26, 2024, 1:25 PM - 1:40 PM EST